MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer
Cancers (Basel), 18 (3)
DOI 10.3390/cancers18030393, PubMed 41681863
The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis
Virchows Arch (in press)
DOI 10.1007/s00428-026-04438-w, PubMed 41656400
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies: How, to whom, and is centralization needed?
Scand J Surg, 14574969261418796 (in press)
DOI 10.1177/14574969261418796, PubMed 41655138